|
Catalogue
Number
|
Product
|
Order number / Unit
|
|
|
5210
|
PD 153035
|
5210.0010: 10 mg per vial
Please inquire for customized
filling and bulk quantities.
|
|
|
Reference standard for [Methoxy-11C]PD 153035
Potent and specific inhibitor of the EFG receptor tyrosine kinase
|
|
|
|
|
|
|
|
|
Molar Mass: 360.21
|
|
|
C16H14BrN3O2
|
|
|
[153436-54-5]
|
|
|
|
|
|
Yellowish solid packaged in dark glass screw cap vials.
|
|
|
|
|
|
|
|
|
Purity: > 95 %
|
|
|
Certificates:
CoA; 1H NMR spectrum
|
|
|
Chemical Name:
CA index name: 4-Quinazolinamine, N-(3-bromphenyl)-6,7-dimethoxy-
|
|
|
Synonymes:
4-(3-Bromphenylamino)-6,7-bis(methoxy)quinazoline; 4-(3-Bromphenylamino)-6,7-dimethylquinazoline; AG 1517; NSC 669364; SU 5271; WHI-P 79
|
|
|
Literature:
1. Fredriksson A. et al. In vivo evaluation of the biodistribution of 11C-labeled PD153035 in rats without and with neuroblastoma implants Life Sci. 1999, 65, 165-174.
|
|
|
2. Johnström P. et al. Synthesis of [Methoxy-11C]PD153035, a Selective EGF Receptor Tyrosine Kinase Inhibitor J. Labelled Compd. Radiopharm. 1998, 41, 623-629.
|
|
|
3. Gibson K.H. et al. Epidermal growth factor receptor tyrosine kinase: Structure-activity relationships and antitumour activity of novel quinazolines Bioorg. Med. Chem. Lett. 1997, 7, 2723-2728.
|
|
|
|
|
|
|
|
|
date of product catalogue issue:
05 April 2012
|